A supplier sends over a data sheet with the word “tested” on it, and the conversation usually stops there. The practice reads “tested” as a stand-in for “works,” files the sheet, and moves on to price and shipping terms.
That substitution is the problem. Most of what gets called testing in professional skincare is a safety or irritation test: a question about tolerance, not about results. It is a legitimate and necessary piece of data. It is also a different question than the one the brochure is answering when it talks about renewal, radiance or clarity. Knowing which question a given test answered is the whole exercise.
An irritation test measures tolerance, not results
A skin irritation or patch test asks one question: does this formulation provoke a reaction on skin over a defined exposure. Volunteers apply or receive the product, and an assessor scores the skin for redness, swelling or other irritation markers against a control.
The output is binary in practice: irritant or non-irritant, sometimes with a grade. That is a real answer to a real safety question, and a supplier who can produce it has done something a supplier who cannot has not. But the test was never designed to measure whether pores look smaller, tone evens out or texture changes. It measures whether the skin tolerated the product, full stop.
What the test does not tell you
An irritation test does not tell you whether the product does what the marketing page says it does. That question belongs to efficacy testing: a separate protocol that measures a defined outcome, usually against a baseline and sometimes against a placebo or comparator, over a set period.
The two get blurred constantly because the language around them is loose. “Dermatologically tested” and “tested on volunteers” can both describe an irritation test, and they usually do, because irritation testing is cheaper and faster to run than efficacy testing. A phrase that does not specify what was measured is not telling you which one you are looking at. Ask directly: tested for what, on what endpoint, read by whom.
A result does not transfer between formats
The same formula sold in two strengths is, for testing purposes, two different products. A result on a lighter version does not carry over to a stronger one, and a result on one finished product does not carry over to a different product that happens to share an ingredient.
This is where suppliers most often overstate what they have. A single irritation test on one format gets cited as evidence for the whole line, including products that were never part of the study. The question to ask is narrow on purpose: which exact format, in which exact concentration, was in the room when the test ran.
Reading our own file honestly
Our own documentation is a working example of what a specific, bounded result looks like. LHALA Peel Basic and Ultra each completed their own skin irritation test, 30 volunteers per format, with a non-irritant result for each. That is two tests, on two named formats, answering the tolerance question for those two products and nothing beyond them.
The Biome Fit Clear Embo Gel Mask has its own safety and patch test, run on 31 adults, also returning a non-irritant result. It is a separate test on a separate product, and it says nothing about the peel or about any other item in the line. Technology pages can describe what an active is built to do in mechanism terms; a technology explanation is not a substitute for a product-specific test, and we try not to let the two blur into each other on our own site.
What supports what. LHALA Peel Basic and Ultra each completed a skin irritation test with 30 volunteers per format, non-irritant result. The Biome Fit Clear Embo Gel Mask completed a separate safety and patch test with 31 adults, also non-irritant. Both are irritation and safety tests, specific to the format tested, and neither measures efficacy or transfers to a product not named in the study.
Five questions to ask any supplier
A short list turns a vague data sheet into a usable one. Ask what exact endpoint the test measured: irritation, sensitization or an efficacy outcome. Ask how many subjects were enrolled and over what period. Ask which specific format and concentration was tested, by name. Ask whether the report itself is available to read, rather than a summary sentence written by marketing. And ask what has not been tested yet, since a supplier willing to name the gap is giving you more useful information than one who claims a complete file.
That last question tends to be the most revealing. A supplier who answers it specifically is treating the practice as the professional buyer it is. A supplier who answers it with reassurance instead of a document is asking you to take the rest of the sheet on faith.
Put the request in writing
None of this requires turning away a supplier over an incomplete file. Most lines, including young import lines, have test coverage for some products and gaps for others. What matters is getting that distinction in writing before a product reaches your treatment room, rather than assuming a single irritation test covers a line it never touched.
If you are building out a Korean peel protocol and want the irritation testing status on a specific SKU before you commit shelf space to it, the U.S. team can send what is on file and flag what is still pending.